Sheila Sherlock

9.3k total citations
195 papers, 6.9k citations indexed

About

Sheila Sherlock is a scholar working on Epidemiology, Hepatology and Pharmacology. According to data from OpenAlex, Sheila Sherlock has authored 195 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Epidemiology, 76 papers in Hepatology and 30 papers in Pharmacology. Recurrent topics in Sheila Sherlock's work include Liver Disease Diagnosis and Treatment (66 papers), Liver Disease and Transplantation (36 papers) and Drug-Induced Hepatotoxicity and Protection (30 papers). Sheila Sherlock is often cited by papers focused on Liver Disease Diagnosis and Treatment (66 papers), Liver Disease and Transplantation (36 papers) and Drug-Induced Hepatotoxicity and Protection (30 papers). Sheila Sherlock collaborates with scholars based in United Kingdom, Mexico and Australia. Sheila Sherlock's co-authors include Marsha Y. Morgan, Michael A. Barry, Peter J. Scheuer, Jhon Prieto, Roger W. Chapman, Judith P. Milsom, Robert Dick, Richard Long, Mark A. Atkinson and M. R. Wills and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Sheila Sherlock

190 papers receiving 6.0k citations

Peers

Countries citing papers authored by Sheila Sherlock

Since Specialization

Citations

This map shows the geographic impact of Sheila Sherlock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheila Sherlock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheila Sherlock more than expected).

Fields of papers citing papers by Sheila Sherlock

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheila Sherlock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheila Sherlock. The network helps show where Sheila Sherlock may publish in the future.

Co-authorship network of co-authors of Sheila Sherlock

This figure shows the co-authorship network connecting the top 25 collaborators of Sheila Sherlock. A scholar is included among the top collaborators of Sheila Sherlock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheila Sherlock. Sheila Sherlock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Drug-Induced Liver Disease 1995 ·Gut ·Sheila Sherlock	68
2	Drugs and the Liver: High Risk Patients and Transplantation 1993 ·D Galmarini, L. R. Fassati, R. Paoletti, Sheila Sherlock	2
3	Fulminant hepatic failure. 1993 ·PubMed ·Sheila Sherlock	19
4	ANTIVIRAL TREATMENT OF CHRONIC HEPATITIS-B VIRUS-INFECTION 1983 ·UCL Discovery (University College London) ·Thomas Hc, I V Weller, A.S. Lok, Sheila Sherlock	1
5	Cholestatic jaundice in fascioliasis treated with niclofolan. 1982 ·BMJ ·Ron Reshef, Anna S. Lok, Sheila Sherlock	9
6	Plasma amino-acid patterns in liver disease. 1982 ·Gut ·Marsha Y. Morgan, (unknown), Judith P. Milsom, Sheila Sherlock	157
7	Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders. 1981 ·Gut ·M Bamber, Alison D. Murray, Bengt Arborgh, Peter J. Scheuer, P. B. A. Kernoff, Howard C. Thomas, Sheila Sherlock	56
8	Granular cell myoblastoma of the common bile duct treated by biliary drainage and surgery. 1981 ·Gut ·Joanna Dewar, James Dooley, Iain Lindsay, (unknown), Sheila Sherlock	11
9	Computed tomography for determining liver iron content in primary haemochromatosis. 1980 ·BMJ ·Roger W. Chapman, Geraint T. Williams, Graeme M. Bydder, Robert Dick, Sheila Sherlock, L Kreel	84
10	Chronic persistent hepatitis: hepatitis B virus markers and histological follow-up. 1979 ·Gut ·R. G. Chadwick, (unknown), Jenny Heathcote, (unknown), B J Cohen, Peter J. Scheuer, Sheila Sherlock	26
11	Effect of oral 1,25 dihydroxycholecalciferol on calcium and phosphate malabsorption in primary biliary cirrhosis. 1979 ·Gut ·Ken Farrington, Owen Epstein, Zac Varghese, Stanton Newman, J F Moorhead, Sheila Sherlock	8
12	Intestinal absorption of cholecalciferol in alcoholic liver disease and primary biliary cirrhosis. 1979 ·Gut ·John Barragry, Richard Long, Michael France, M. R. Wills, Barbara J. Boucher, Sheila Sherlock	35
13	The British Society of Gastroenterology 1978 ·Gut ·W. Sircus, (unknown), G Holdstock, Martin Wiseman, C A Loehry, Allan D. Kirk, Richard H. Hunt, James Dooley, Sheila Sherlock, C. A. Campbell, Christopher J.M. Williams, J A Walker‐Smith, Gordon R. Greenberg, R F McCloy, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
14	Ascorbic acid deficiency in liver disease. 1976 ·Gut ·(unknown), Sheila Sherlock	38
15	Diagnosis of Gilbert's Syndrome: Role of Reduced Caloric Intake Test 1973 ·BMJ ·D. Owens, Sheila Sherlock	76
16	Skeletal muscle blood flow and neurovascular reactivity in liver disease 1973 ·Gut ·Michael R. Lunzer, Stanton Newman, Sheila Sherlock	48
17	Serum autoantibodies and immunoglobulins in hepatitis-associated antigen (HAA)-positive and -negative liver disease 1973 ·Gut ·F. J. Dudley, (unknown), A. B. Ajdukiewicz, Sheila Sherlock	24
18	Copper kinetics in liver disease 1971 ·Gut ·R. A. Smallwood, (unknown), Victor M. Rosenoer, Sheila Sherlock	19
19	The British Society of Gastroenterology 1969 ·Gut ·(unknown), (unknown), Robert K. Crane, R. Holmes, John Edward Lennard-Jones, A. A. Harper, Sheila Sherlock, Mark A. Atkinson, (unknown), (unknown), (unknown), S. J. M. Goulston, K Heinkel, John H. Landor, J. Myren, C. J. Edmonds, T S Low-Beer, Leon Lack, Malcolm P. Tyor, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
20	Chronic Cholangitides: Aetiology, Diagnosis, and Treatment 1968 ·BMJ ·Sheila Sherlock	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact